Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameScinai Immunotherapeutics Ltd
-
Registration countryIsrael
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









